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We earlier demonstrated, in a randomised clinical trial, that the regression time of flat penile lsions in male sexual partners of women
with cervical intraepithelial neoplasia (CIN) was shorter in men who used condoms compared to those who did not. To further
evaluate this finding, we examined whether the effect of condom use on the regression of flat penile lesions depends on the presence
of human papillomavirus (HPV) type concordance in sexual couples, as determined in cervical and penile scrapes by GP5þ/6þ PCR
testing. A Cox model with time-dependent covariates showed a beneficial effect of condoms on regression of flat penile lesions in
concordant couples (hazard ratio 2.63, 95% CI 1.07–6.48) but not in those who were nonconcordant. When both partners
harboured different HPV types, no effect of condoms was found (hazard ratio 0.90, 95% CI 0.27–2.96). Delayed regression of flat
penile lesions was associated with either stable lesions or with new penile lesions developing at sites surrounding pre-existing lesions
suggesting reinfection of the penile epithelium. We conclude that condom use blocks sexual HPV transmission by preventing
reinfection and development of new penile lesions in men who are susceptible to the same type as present in the female partner.
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Infection with high-risk types of human papillomavirus (HPV) is
the major cause of cervical cancer and its precursor lesions
(Schiffman et al, 1993; Walboomers et al, 1999; Bosch et al, 2002;
Munoz et al, 2003). Human papillomavirus has also been linked to
cancers of the vulva, vagina, anus, and penis (IARC 1995; Melbye
and Frisch, 1998). Genital HPV types are transmitted sexually and
the risk of infection has been associated with numerous
parameters involving sexual behaviour (Franco et al, 1995; Bosch
et al, 1996; Kjaer et al, 2001).
Partner studies have shown that penile lesions are found in more
than half of the male partners of women with cervical intraepi-
thelial neoplasia (CIN) (Barrasso et al, 1987; Campion et al, 1988;
Hippelainen M et al, 1991; Bleeker et al, 2002). Flat lesions are
reported as the most prevalent lesion type and their relationship
with HPV has been established (Barrasso et al, 1987; Campion
et al, 1988; Hippelainen M et al, 1991; Hippelainen MI et al, 1993b;
Bleeker et al, 2002). Since flat penile lesions are only well visible
after acetowhitening, their presence remains often unnoticed. This
explains why the natural history of penile lesions and HPV
infection in men has not been studied extensively and is largely
unknown.
We have recently shown that the presence of penile HPV is
associated with delayed regression whereas condom use revealed
accelerated regression (Bleeker et al, 2003). The beneficial effect of
condom intervention on regression of penile lesions suggests that a
sexual transmittable factor, that is, most likely cervical HPV,
influences the clinical course of these lesions. To evaluate this
hypothesis, the effect of condom use on regression of flat penile
lesions was studied in relation to the presence of HPV type
concordance between sexual partners. Since use of condoms and
presence of concordance could change during this prospective
study, effects of condom use were estimated by a Cox model with
time-dependent covariates.
PATIENTS AND METHODS
Study population
The study population consisted of men recruited at the colposcopy
clinic of the Albert Schweitzer Hospital, Dordrecht, the Netherlands,
from January 1995 to June 2002. These men participated in a
randomised clinical trial, studying the influence of condom use on
regression of CIN and penile lesions in sexual couples. Details of
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sthis trial have been described recently (Bleeker et al, 2003;
Hogewoning et al, 2003). Men were screened for penile lesions by
penoscopy and a penile scrape was taken for HPV PCR testing.
Women were screened by colposcopy and scrapes were taken for
cytology and HPV testing. Baseline cervical biopsy specimens were
taken for histopathological evaluation. Couples were randomised to
either condom use or not using a block randomisation scheme with
block size two. Condoms were proposed for at least 3 months and
randomisation occurred independent of the presence of HPV, penile
lesions, grade of CIN lesion, or surgical treatment of the CIN lesion.
Exclusion criterion was regular condom use at baseline. Follow-up
examinations were carried out after 3 and 6 months and
subsequently every 6 months. In the condom arm, condom use
was verified at each visit by asking the frequency of failures to use
condoms. Partners were not asked separately for the number of
failures and, in case of discrepancies between partners, the couples
themselves made a consensus. Also, couples assigned to the
noncondom arm were asked during each follow-up visit whether
they have used condoms but none of them reported condom use. To
obtain information on lifestyle habits, including sexual behaviour,
couples were asked to complete a questionnaire. This questionnaire
was introduced in 1999 and completed, independently by each
partner, in separate rooms. The medical ethics review board of the
hospital approved the study protocol (protocol number: CGE/95/
238) and the participants signed informed consents.
Data collection
Penoscopic examination Penoscopic examination and specimen
collection were performed as described earlier by us (Bleeker et al,
2002). Briefly, using a Cervex brush
s, a penile scrape for HPV
testing was taken to collect cells from the glans, corona, sulcus,
frenulum, and inner part of the foreskin. Subsequently, a
colposcope was used to identify flat penile lesions after the
application of 3% acetic acid solution. Follow-up penoscopic
examinations were performed blinded of data from previous visits.
Findings were written on a standardised form and penile lesions
were documented by digital photography. Photographs were
subsequently reviewed and graded by an experienced dermatolo-
gist (TMS), unaware of any clinical data. In case of discrepancies
(o5%) between the initial finding and the review result, a
consensus diagnoses was made with the gynaecologist who made
the photographs and the dermatologist who reviewed the
photographs.
Human papillomavirus testing Processing of specimens and
testing for HPV was carried out at the Department of Pathology,
VU University Medical Center, as described previously (Jacobs
et al, 1997; Bleeker et al, 2002). In short, DNA quality was tested by
b-globin PCR and testing for HPV was carried out using the HPV
GP5þ/6þ PCR enzyme immunoassay (HPV PCR-EIA), to
identify 14 high-risk (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59,
66, and 68) and six low-risk (6, 11, 40, 42, 43, and 44) HPV
genotypes with a high-risk and a low-risk HPV probe cocktail,
respectively. Additionally, individual typing was performed for
HPV 16, 18, 31, 33, 6, and 11, using type-specific probes in an EIA
format. Samples, which were inadequate for HPV testing, that is,
were negative in both b-globin and HPV PCR assays, were
excluded from the analysis.
Regression of flat penile lesions
In 75% of the men with flat penile lesions, more than 5mm
2 of the
penile epithelium was affected and in 94% of them more than one
lesion was present (Bleeker et al, 2005). Follow-up of individual flat
penile lesions was sometimes difficult, especially when lesions were
small and present on multiple sites of the penis. Larger lesions
were usually localized on the same site of the penile epithelium and
could vary in size. Owing to this diverse clinical presentation,
regression was defined as disappearance of all detectable flat
lesions, that is, no flat lesions at penoscopy.
Statistical analysis
Differences in characteristics of the condom and the noncondom
groups were assessed by use of w
2 or Student’s t-tests (two-tailed,
Po0.05), where appropriate.
The outcome of interest in this study was regression of flat
penile lesions. To study the complex interrelationship between
HPV presence, concordance, and condom use on the regression of
the penile lesions, we choose an approach in which changes in
condom use or presence of female HPV infection during the study
could be included. Therefore, to examine whether the effect of
condom use on regression of flat penile lesions was related to the
presence of HPV type concordance in sexual couples, Cox
regression analysis with time-dependent covariates (condom use
and presence of female HPV) was performed to compute hazard
ratios and 95% confidence intervals (CI). In the modelling process,
hazard ratios for the effect of condom use were computed using
the noncondom group as the reference group in couples with a
comparable HPV status.
The HPV status in men was defined as positive or negative
when penile scrapes were ever or never HPV positive during the
study, respectively (Bleeker et al, 2003). Other determinants
assessed were CIN grade of the female partner at baseline
histology (either pCIN 1 or XCIN 2) and age of the men when
entering the study.
Originally, sexual couples were considered as HPV type
concordant when both sexual partners were positive for HPV 16,
18, 31, 33, 6, 11, other high-risk HPVs (not HPV type 16, 18, 31, or
33) and/or other low-risk HPV (not HPV type 6 and 11) during the
study. This definition was used because of practical reasons that
individual typing was only performed for HPV 16, 18, 31, 33, 6, and
11, whereas other high-risk HPVs and other low-risk HPVs each
typed as a group. A more restrictive definition of concordance was
subsequently used including only the couples that were concordant
for 16, 18, 31, 33, 6, and/or 11 and excluding the couples that were
concordant for other high-risk and/or other low-risk HPV types.
For Cox regression analyses with time-dependent covariates,
Stata 6.0 was used and for the remaining analyses SPSS version 9.0
software.
RESULTS
Study population
A total of 139 men had flat penile lesions at baseline. Six of them
used condoms at baseline and were excluded from this study. No
follow-up results were available from 14 men, and in one female
partner the presence of HPV could not be determined due to
inadequate sample quality at baseline. The remaining 118 men
formed the study population. At baseline, 61 (51.7%) couples
started condom use and 57 (48.3%) did not. The median duration
of condom use was 5.3 months (range 2.5–53.7). Failures of
condom use were reported by six couples with a median of 1.5
times during the follow-up period (range 1–2). The median follow-
up time of the study population was 12.5 months (range 2.5–77.5):
12.9 months (range 3.0–68.5) in the noncondom and 12.3 months
(range 2.5–77.5) in the condom group (P¼0.388).
Baseline characteristics of the study population are presented in
Table 1 and no statistically significant differences were found
between the condom and the noncondom group. The mean age of
men was 38.7 years (range 28.1–57.7 years) and of women 36.2
years (range 22.6–54.9). Representative biopsy specimens were
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savailable for 111 women: 17 had no CIN (15.3%), 34 CIN 1 (30.6%),
39 CIN 2 (35.1%), and 21 XCIN 3 (18.9%). At baseline, 85.6% of
the women and 68.6% of the men were positive for HPV DNA.
Human papillomavirus 16 was found in 59.4 and 55.9% of the
positive women and men, respectively, and their prevalences were
not statistically different in the condom and the noncondom group
(P¼0.496 in women and P¼0.775 in men). Women with HPV at
baseline (n¼101) had a median duration of HPV infection of 9.2
months and were not statistically different in the condom and
noncondom group (P¼0.852).
During the study, at least one concordant HPV type was found
in 57 couples: 32 couples of the condom and 25 couples of the
noncondom group (P¼0.350). Human papillomavirus type
concordance was found for HPV 16 in 33 (58%), HPV 18 in 0
(0%), HPV 31 in two (4%), HPV 33 in two (4%), other high-risk
HPV type in eight (14%), HPV 6 in one (2%), HPV 11 in zero (0%),
other low-risk HPV type in three (5%), and multiple HPV types in
eight (14%) couples, that is, HPV 16 and 31 (n¼1), HPV 16 and
other high-risk type (n¼4), HPV 16 and 6 (n¼1), HPV 33 and
other low-risk type (n¼1), and other high-risk and other low-risk
HPV (n¼1). Concordance for HPV 16 was equally prevalent in the
condom and the noncondom groups (P¼0.952).
Effect of condom use on regression of flat penile lesions in
concordant and nonconcordant sexual couples
Using a Cox model with time-dependent covariates, we examined
whether the effect of condom use on regression of flat penile lesions
was related to the presence of HPV type concordance in sexual
partners. This analysis showed that the beneficial effect of condoms
on regression of flat penile lesions was present in concordant
couples (hazard ratio 2.63, 95% CI 1.07–6.48, P¼0.035, Table 2)
but not in those who were nonconcordant. Also, no effect of
condoms was found when both partners were positive but
nonconcordant (hazard ratio 0.90, 95% CI 0.27–2.96, P¼0.861).
The estimated hazard ratio for the effect of condom use when
comparing the concordant and the nonconcordant HPV-positive
couples was 2.63/0.90¼2.93, 95% CI 0.66–13.07 (P¼0.159).
When we restricted the analysis to couples concordant for
HPV types 6, 11, 16, 18, 31, and 33, which were individually
typed during this study, similar effects of condom use were
obtained.
Regression of flat penile lesions was not related to the age of the
men (hazard ratio 0.99, 95% CI 0.95–1.03, P¼0.501) or the
histological CIN grade (hazard ratio 1.27, 95% CI 0.71–2.25,
Table 1 Baseline characteristics of the study population
Condom– Condom+
N % N % N %
Subjects 118 100 57 48.3 61 51.7
Age
Men 38.7 38.9 38.5
Women 36.2 36.1 36.3
Histological CIN grade in female partner
No (representative) biopsy 7 4 3
No CIN 17 15.3 10 18.9 7 12.1
CIN 1 34 30.6 15 28.3 19 32.8
CIN 2 39 35.1 15 28.3 24 41.4
XCIN 3 21 18.9 13 24.5 8 13.8
Cervical HPV
Negative 17 14.4 11 19.3 6 9.8
Positive 101 85.6 46 80.7 55 90.2
Penile HPV
Inadequate
a 32 19 13
Negative 27 31.4 12 31.6 15 31.3
Positive 59 68.6 26 68.4 33 68.8
aCould not be determined because samples were inadequate for HPV testing. HPV¼human papillomavirus; CIN¼cervical intraepithelial neoplasia.
Table 2 Effect of condom use on regression of flat penile lesions
Effect of condom use
a
Cervical HPV Penile HPV Hazard ratio 95% CI P
Nonconcordant Nonconcordant
Negative Negative 1.02 0.10–10.11 0.986
Positive 1.04 0.07–15.55 0.978
Positive Negative 2.40 0.47–12.36 0.294
Positive 0.90 0.27–2.96 0.862
Concordant Concordant
Positive Positive 2.63 1.07–6.48 0.035
aCox regression analyses with time-dependent predictors (cervical HPV and condoms) were performed to compute 95% CI of the hazard ratios for the effect of condom use vs
no use of condoms. Boldface numbers indicate statistical significance. CI¼confidence interval; HPV¼human papillomavirus.
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sP¼0.418). Inclusion of these determinants into the Cox model did
not markedly change the hazard ratios for condom use.
In case of a delayed regression of flat penile lesions, we observed
that either the lesions were stable or that new penile lesions
developed at sites surrounding pre-existing lesions suggesting
reinfection of the penile epithelium. Hence, a diverse clinical
course of flat penile lesions was noticed which was present in both
the condom and the noncondom arm.
DISCUSSION
Our data, collected in a randomised clinical trial, earlier demon-
strated that the regression time of flat penile lesions was shorter in
men who used condoms compared to those who did not (Bleeker
et al, 2003). We hypothesised that sexually transmittable HPV of the
women delayed regression of flat penile lesions in their male partner
and that condoms could effectively block HPV transmission. In the
present study, we examined whether the effect of condom use on
regression of flat penile lesions depended on the presence of HPV
concordance between sexual partners. Indeed, using a Cox model in
which changes on condom use and presence of HPV concordance
during this study were included, a beneficial effect of condoms on
regression of penile lesions was found for HPV type concordant
couples, but not for those who were not concordant.
The presence of penile lesions associated with a given HPV type
indicates that the man is susceptible for this particular HPV type.
In men with penile lesions who harboured a similar HPV type as
their female partner, we observed a delayed regression when
couples did not use condoms compared to those who did. This
finding suggests that failure of penile lesions to cure depends on
reinfection by cervical HPV from the female partner for which the
man is apparently susceptible. This is substantiated by the
observation that new penile lesions often developed next to pre-
existing ones. The beneficial effect of condom use in HPV
concordant couples can be explained by blocking HPV transmis-
sion during sexual intercourse, thereby preventing reinfection and
development of new penile lesions. In nonconcordant couples, we
found no effect of condom use on regression of penile lesions.
Apparently, these men are not susceptible for the development of
new lesions by the HPV type, which is present in the female
partner. Consequently, the clinical implication of our findings
would be that condoms sort only effect in heterosexual couples
that are positive for the same HPV type and that, in these couples,
condom use should be continued as long as the female partner is
HPV positive. In addition, condom use could also be advocated in
sexual couples of whom the woman is HPV positive and the male
partner does not have penile lesions since we do not know whether
the male partner is susceptible for the HPV type of the woman and
thus can acquire a penile lesion.
So far, studies on the effectiveness of condoms in relation to the
prevention of HPV infection and related disorders were mainly
focused on women and available data were too inconsistent to
provide precise estimates (Manhart and Koutsky, 2002). Only a
few studies were performed in men and reported that consistent
condom use reduced the risk for genital warts or subclinical HPV
infection (Hippelainen M et al, 1993a; Wen et al, 1999). Of interest
is the work of Hippelainen MI et al (1994) who found that condom
use had a positive effect on the cure rate of genital HPV lesions in
male partners of HPV-infected women. However, all studies
evaluating condom use were either cross-sectional or observa-
tional and not explicitly designed to evaluate condom use
prospectively.
In this partner study, however, it should be realised that
grouping into concordant and nonconcordant may be subject to
some degree of underestimation of concordant sexual couples.
Nondetection of HPV in penile scrapes does not necessarily reflect
absence of HPV (Bleeker et al, 2003). Compared to cervical
scrapings, low cell numbers are collected by scraping the penile
epithelium and consequently low numbers of infected cells might
have been missed during the sampling. Therefore, because of
potential false negativity in penile scrapes, the currently defined
group of nonconcordant couples may contain some concordant
couples as well. This may explain the hazard ratio of 2.40 (95% CI
0.47–12.36) in nonconcordant couples in whom the woman was
HPV positive and the man negative. Another issue is that we did
not ask the couples to keep a log of their condom use. Therefore,
recall bias cannot be completely excluded but it is unlikely that this
substantially influenced the data as the number of failures to use
condoms was low. Moreover, failures to use condoms would most
likely lower the positive effect of condoms on regression of the
penile lesions, meaning that the effect of condoms would even be
more beneficial when there were no failures of condom use at all.
In conclusion, the beneficial effect of condoms on regression of
flat penile lesions was only found when sexual couples were HPV
concordant. The effect of condoms is probably the result of
blocking transmission of female HPV to the penis, thereby
preventing reinfection and induction of a penile lesion to which
a man is susceptible. As HPV testing becomes more widely used
both for the management of women with HPV-related disorders
and in cervical screening programs, accurate information on how
to protect against HPV is needed. Our data suggest that condom
use can reduce the spread of HPV in a sexually active population.
Our findings warrant further studies on this topic.
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